Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06588465
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-05
Brief Title:
Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients a Single Center Randomized Assessor- and Participant-blind Controlled Cross-over Clinical Trial
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The single center randomized assessor- and participant-blind controlled cross-over on-venous laser irradiation of blood clinical trial was performed to analyze patients with DKD The information will help to whether integration of laser acupuncture into patient care will help to improve the clinical symptoms and quality of life
Detailed Description:
Microalbuminuria is the cardinal symptom of diabetes kidney disease DKD and is linked to renal function decline The cardiovascular risk of patients with DKD is much higher than that of the general population and cardiovascular diseases is the main cause of death in patients with DKD
We plan to enroll 72 volunteer patients with microalbuminuria After 1 week waiting period as the waiting list group the patients will be randomized to on-venous laser irradiation of blood and low dose OLIB group Each group will include 36 patients and given intervention three times a week The intervention will then be crossed over to the other one after 1 week of wash-our period Outcome measurement includes questionnaires biochemistry analysis urine routine analysis
We plan to enroll 72 volunteer patients with microalbuminuria After 1 week waiting period as the waiting list group the patients will be randomized to on-venous laser irradiation of blood and low dose OLIB group Each group will include 36 patients and given intervention three times a week The intervention will then be crossed over to the other one after 1 week of wash-our period Outcome measurement includes questionnaires biochemistry analysis urine routine analysis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None